 | • レポートコード：QYR2104Z3592 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、麻疹のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗ウイルス剤、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・麻疹の市場動向 ・企業の競争状況、市場シェア ・麻疹の種類別市場規模（抗生物質、抗ウイルス剤、ワクチン） ・麻疹の用途別市場規模（病院、クリニック、その他） ・麻疹の北米市場規模2016-2027（アメリカ、カナダ） ・麻疹のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・麻疹のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・麻疹の中南米市場規模2016-2027（メキシコ、ブラジル） ・麻疹の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Abbott、Biomedical Diagnostics、Johnson & Johnson Services、Sanofi、Merck、Serum Institute Of India） ・結論 |
Measles is a highly contagious infectious disease caused by the measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104.0 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik’s spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Complications occur in about 30% of cases and may include diarrhea, blindness, inflammation of the brain, and pneumonia, among others.
There is no specific antiviral treatment if measles develops. Instead the medications are generally aimed at treating super infections, maintaining good hydration with adequate fluids, and pain relief. Some groups are also given vitamin A, like young children and the severely malnourished, which act as an immunomodulator that boosts the antibody responses to measles and decreases the risk of serious complications.
Market Analysis and Insights: Global Measles Market
The global Measles market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Measles market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Measles market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Measles market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Measles market.
Global Measles Scope and Market Size
Measles market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Measles market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Treatment and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Treatment
Antibiotic
Antiviral
Vaccine
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Abbott
Biomedical Diagnostics
Johnson & Johnson Services
Sanofi
Merck
Serum Institute Of India
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
1.2.2 Antibiotic
1.2.3 Antiviral
1.2.4 Vaccine
1.3 Market by Application
1.3.1 Global Measles Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Measles Market Perspective (2016-2027)
2.2 Measles Growth Trends by Regions
2.2.1 Measles Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Measles Historic Market Share by Regions (2016-2021)
2.2.3 Measles Forecasted Market Size by Regions (2022-2027)
2.3 Measles Industry Dynamic
2.3.1 Measles Market Trends
2.3.2 Measles Market Drivers
2.3.3 Measles Market Challenges
2.3.4 Measles Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Measles Players by Revenue
3.1.1 Global Top Measles Players by Revenue (2016-2021)
3.1.2 Global Measles Revenue Market Share by Players (2016-2021)
3.2 Global Measles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Measles Revenue
3.4 Global Measles Market Concentration Ratio
3.4.1 Global Measles Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Measles Revenue in 2020
3.5 Measles Key Players Head office and Area Served
3.6 Key Players Measles Product Solution and Service
3.7 Date of Enter into Measles Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Measles Breakdown Data by Treatment
4.1 Global Measles Historic Market Size by Treatment (2016-2021)
4.2 Global Measles Forecasted Market Size by Treatment (2022-2027)
5 Measles Breakdown Data by Application
5.1 Global Measles Historic Market Size by Application (2016-2021)
5.2 Global Measles Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Measles Market Size (2016-2027)
6.2 North America Measles Market Size by Treatment
6.2.1 North America Measles Market Size by Treatment (2016-2021)
6.2.2 North America Measles Market Size by Treatment (2022-2027)
6.2.3 North America Measles Market Size by Treatment (2016-2027)
6.3 North America Measles Market Size by Application
6.3.1 North America Measles Market Size by Application (2016-2021)
6.3.2 North America Measles Market Size by Application (2022-2027)
6.3.3 North America Measles Market Size by Application (2016-2027)
6.4 North America Measles Market Size by Country
6.4.1 North America Measles Market Size by Country (2016-2021)
6.4.2 North America Measles Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Measles Market Size (2016-2027)
7.2 Europe Measles Market Size by Treatment
7.2.1 Europe Measles Market Size by Treatment (2016-2021)
7.2.2 Europe Measles Market Size by Treatment (2022-2027)
7.2.3 Europe Measles Market Size by Treatment (2016-2027)
7.3 Europe Measles Market Size by Application
7.3.1 Europe Measles Market Size by Application (2016-2021)
7.3.2 Europe Measles Market Size by Application (2022-2027)
7.3.3 Europe Measles Market Size by Application (2016-2027)
7.4 Europe Measles Market Size by Country
7.4.1 Europe Measles Market Size by Country (2016-2021)
7.4.2 Europe Measles Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Measles Market Size (2016-2027)
8.2 Asia-Pacific Measles Market Size by Treatment
8.2.1 Asia-Pacific Measles Market Size by Treatment (2016-2021)
8.2.2 Asia-Pacific Measles Market Size by Treatment (2022-2027)
8.2.3 Asia-Pacific Measles Market Size by Treatment (2016-2027)
8.3 Asia-Pacific Measles Market Size by Application
8.3.1 Asia-Pacific Measles Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Measles Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Measles Market Size by Application (2016-2027)
8.4 Asia-Pacific Measles Market Size by Region
8.4.1 Asia-Pacific Measles Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Measles Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Measles Market Size (2016-2027)
9.2 Latin America Measles Market Size by Treatment
9.2.1 Latin America Measles Market Size by Treatment (2016-2021)
9.2.2 Latin America Measles Market Size by Treatment (2022-2027)
9.2.3 Latin America Measles Market Size by Treatment (2016-2027)
9.3 Latin America Measles Market Size by Application
9.3.1 Latin America Measles Market Size by Application (2016-2021)
9.3.2 Latin America Measles Market Size by Application (2022-2027)
9.3.3 Latin America Measles Market Size by Application (2016-2027)
9.4 Latin America Measles Market Size by Country
9.4.1 Latin America Measles Market Size by Country (2016-2021)
9.4.2 Latin America Measles Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Measles Market Size (2016-2027)
10.2 Middle East & Africa Measles Market Size by Treatment
10.2.1 Middle East & Africa Measles Market Size by Treatment (2016-2021)
10.2.2 Middle East & Africa Measles Market Size by Treatment (2022-2027)
10.2.3 Middle East & Africa Measles Market Size by Treatment (2016-2027)
10.3 Middle East & Africa Measles Market Size by Application
10.3.1 Middle East & Africa Measles Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Measles Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Measles Market Size by Application (2016-2027)
10.4 Middle East & Africa Measles Market Size by Country
10.4.1 Middle East & Africa Measles Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Measles Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Measles Introduction
11.1.4 Novartis Revenue in Measles Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Measles Introduction
11.2.4 Abbott Revenue in Measles Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Biomedical Diagnostics
11.3.1 Biomedical Diagnostics Company Details
11.3.2 Biomedical Diagnostics Business Overview
11.3.3 Biomedical Diagnostics Measles Introduction
11.3.4 Biomedical Diagnostics Revenue in Measles Business (2016-2021)
11.3.5 Biomedical Diagnostics Recent Development
11.4 Johnson & Johnson Services
11.4.1 Johnson & Johnson Services Company Details
11.4.2 Johnson & Johnson Services Business Overview
11.4.3 Johnson & Johnson Services Measles Introduction
11.4.4 Johnson & Johnson Services Revenue in Measles Business (2016-2021)
11.4.5 Johnson & Johnson Services Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Measles Introduction
11.5.4 Sanofi Revenue in Measles Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Measles Introduction
11.6.4 Merck Revenue in Measles Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Serum Institute Of India
11.7.1 Serum Institute Of India Company Details
11.7.2 Serum Institute Of India Business Overview
11.7.3 Serum Institute Of India Measles Introduction
11.7.4 Serum Institute Of India Revenue in Measles Business (2016-2021)
11.7.5 Serum Institute Of India Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Measles Market Size Growth Rate by Treatment (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotic
Table 3. Key Players of Antiviral
Table 4. Key Players of Vaccine
Table 5. Global Measles Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Measles Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Measles Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Measles Market Share by Regions (2016-2021)
Table 9. Global Measles Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Measles Market Share by Regions (2022-2027)
Table 11. Measles Market Trends
Table 12. Measles Market Drivers
Table 13. Measles Market Challenges
Table 14. Measles Market Restraints
Table 15. Global Measles Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Measles Market Share by Players (2016-2021)
Table 17. Global Top Measles Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles as of 2020)
Table 18. Ranking of Global Top Measles Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Measles Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Measles Product Solution and Service
Table 22. Date of Enter into Measles Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Measles Market Size by Treatment (2016-2021) (US$ Million)
Table 25. Global Measles Revenue Market Share by Treatment (2016-2021)
Table 26. Global Measles Forecasted Market Size by Treatment (2022-2027) (US$ Million)
Table 27. Global Measles Revenue Market Share by Treatment (2022-2027) & (US$ Million)
Table 28. Global Measles Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Measles Revenue Market Share by Application (2016-2021)
Table 30. Global Measles Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Measles Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Measles Market Size by Treatment (2016-2021) (US$ Million)
Table 33. North America Measles Market Size by Treatment (2022-2027) & (US$ Million)
Table 34. North America Measles Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Measles Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Measles Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Measles Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Measles Market Size by Treatment (2016-2021) (US$ Million)
Table 39. Europe Measles Market Size by Treatment (2022-2027) & (US$ Million)
Table 40. Europe Measles Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Measles Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Measles Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Measles Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Measles Market Size by Treatment (2016-2021) (US$ Million)
Table 45. Asia-Pacific Measles Market Size by Treatment (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Measles Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Measles Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Measles Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Measles Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Measles Market Size by Treatment (2016-2021) (US$ Million)
Table 51. Latin America Measles Market Size by Treatment (2022-2027) & (US$ Million)
Table 52. Latin America Measles Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Measles Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Measles Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Measles Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Measles Market Size by Treatment (2016-2021) (US$ Million)
Table 57. Middle East & Africa Measles Market Size by Treatment (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Measles Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Measles Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Measles Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Measles Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Measles Product
Table 65. Novartis Revenue in Measles Business (2016-2021) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Measles Product
Table 70. Abbott Revenue in Measles Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Biomedical Diagnostics Company Details
Table 73. Biomedical Diagnostics Business Overview
Table 74. Biomedical Diagnostics Measles Product
Table 75. Biomedical Diagnostics Revenue in Measles Business (2016-2021) & (US$ Million)
Table 76. Biomedical Diagnostics Recent Development
Table 77. Johnson & Johnson Services Company Details
Table 78. Johnson & Johnson Services Business Overview
Table 79. Johnson & Johnson Services Measles Product
Table 80. Johnson & Johnson Services Revenue in Measles Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Services Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Measles Product
Table 85. Sanofi Revenue in Measles Business (2016-2021) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Measles Product
Table 90. Merck Revenue in Measles Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Serum Institute Of India Company Details
Table 93. Serum Institute Of India Business Overview
Table 94. Serum Institute Of India Measles Product
Table 95. Serum Institute Of India Revenue in Measles Business (2016-2021) & (US$ Million)
Table 96. Serum Institute Of India Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Measles Market Share by Treatment: 2020 VS 2027
Figure 2. Antibiotic Features
Figure 3. Antiviral Features
Figure 4. Vaccine Features
Figure 5. Global Measles Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Measles Report Years Considered
Figure 10. Global Measles Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Measles Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Measles Market Share by Regions: 2020 VS 2027
Figure 13. Global Measles Market Share by Regions (2022-2027)
Figure 14. Global Measles Market Share by Players in 2020
Figure 15. Global Top Measles Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Measles Revenue in 2020
Figure 17. Global Measles Revenue Market Share by Treatment (2016-2021)
Figure 18. Global Measles Revenue Market Share by Treatment (2022-2027)
Figure 19. North America Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Measles Market Share by Treatment (2016-2027)
Figure 21. North America Measles Market Share by Application (2016-2027)
Figure 22. North America Measles Market Share by Country (2016-2027)
Figure 23. United States Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Measles Market Share by Treatment (2016-2027)
Figure 27. Europe Measles Market Share by Application (2016-2027)
Figure 28. Europe Measles Market Share by Country (2016-2027)
Figure 29. Germany Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Measles Market Share by Treatment (2016-2027)
Figure 37. Asia-Pacific Measles Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Measles Market Share by Region (2016-2027)
Figure 39. China Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Measles Market Share by Treatment (2016-2027)
Figure 47. Latin America Measles Market Share by Application (2016-2027)
Figure 48. Latin America Measles Market Share by Country (2016-2027)
Figure 49. Mexico Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Measles Market Share by Treatment (2016-2027)
Figure 53. Middle East & Africa Measles Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Measles Market Share by Country (2016-2027)
Figure 55. Turkey Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Measles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Measles Business (2016-2021)
Figure 59. Abbott Revenue Growth Rate in Measles Business (2016-2021)
Figure 60. Biomedical Diagnostics Revenue Growth Rate in Measles Business (2016-2021)
Figure 61. Johnson & Johnson Services Revenue Growth Rate in Measles Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Measles Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Measles Business (2016-2021)
Figure 64. Serum Institute Of India Revenue Growth Rate in Measles Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のTBワクチン治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global TB Vaccine Treatment Market The global TB Vaccine Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…- 世界のC型肝炎ウイルス（HCV）用抗ウイルス剤市場規模・現状・予測（2021年-2027年） Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…
- 世界のニューカッスル病治療市場規模・現状・予測（2021年-2027年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
- 世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…
- 世界の食用ワクチン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Edible Vaccine Market The global Edible Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…